Anne Sibille

1.3k total citations
21 papers, 204 citations indexed

About

Anne Sibille is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Anne Sibille has authored 21 papers receiving a total of 204 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 10 papers in Pulmonary and Respiratory Medicine and 2 papers in Molecular Biology. Recurrent topics in Anne Sibille's work include Lung Cancer Treatments and Mutations (8 papers), Lung Cancer Research Studies (6 papers) and Lung Cancer Diagnosis and Treatment (5 papers). Anne Sibille is often cited by papers focused on Lung Cancer Treatments and Mutations (8 papers), Lung Cancer Research Studies (6 papers) and Lung Cancer Diagnosis and Treatment (5 papers). Anne Sibille collaborates with scholars based in Belgium, Netherlands and United States. Anne Sibille's co-authors include Bernard Duysinx, Renaud Louis, Vincent Ninane, Guy Jérusalem, Jean-Louis Corhay, J L Corhay, Johan Vansteenkiste, Junya Fujimoto, Patricia M. de Groot and Dmitry Bentsion and has published in prestigious journals such as Annals of Neurology, Clinical Cancer Research and International Journal of Molecular Sciences.

In The Last Decade

Anne Sibille

20 papers receiving 203 citations

Peers

Anne Sibille

ONCOL

PRM

RNMI

EPIDE

Weigang Xiu China

Norimitsu Kasahara Japan

Elisabetta Gambale Italy

Anna Couvillon United States

Christopher Rossmann Austria

Ewa Wasilewska-Teśluk Poland

Masayuki Shirasawa Japan

Margaux Geier France

Robert Šeparović Croatia

Junlong Xu China

Weigang Xiu China

Anne Sibille

122 ×0.9

ONCOL

51 ×0.6

PRM

44 ×0.8

20 ×0.6

RNMI

22 ×0.8

EPIDE

Citations per year, relative to Anne Sibille Anne Sibille (= 1×) peers Weigang Xiu

Countries citing papers authored by Anne Sibille

Since Specialization

Citations

This map shows the geographic impact of Anne Sibille's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Sibille with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Sibille more than expected).

Fields of papers citing papers by Anne Sibille

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Sibille. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Sibille. The network helps show where Anne Sibille may publish in the future.

Co-authorship network of co-authors of Anne Sibille

This figure shows the co-authorship network connecting the top 25 collaborators of Anne Sibille. A scholar is included among the top collaborators of Anne Sibille based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne Sibille. Anne Sibille is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cousin, François, Thomas Louis, Frank Aboubakar Nana, et al.. (2023). Radiomics and Delta-Radiomics Signatures to Predict Response and Survival in Patients with Non-Small-Cell Lung Cancer Treated with Immune Checkpoint Inhibitors. Cancers. 15(7). 1968–1968. 25 indexed citations

Gester, Fanny, et al.. (2023). Prognostic factors in non-small cell lung cancer. Frontiers research topics. 71(1). 34–9. 1 indexed citations

Byers, Lauren A., Dmitry Bentsion, Steven Gans, et al.. (2021). Veliparib in Combination with Carboplatin and Etoposide in Patients with Treatment-Naïve Extensive-Stage Small Cell Lung Cancer: A Phase 2 Randomized Study. Clinical Cancer Research. 27(14). 3884–3895. 52 indexed citations

Sibille, Anne, et al.. (2021). White Blood Cells in Patients Treated with Programmed Cell Death-1 Inhibitors for Non-small Cell Lung Cancer. Lung. 199(5). 549–557. 10 indexed citations

Smit, Hans J.M., Anne Sibille, Fiona McDonald, et al.. (2021). 1171MO PACIFIC-R real-world study: Treatment duration and interim analysis of progression-free survival in unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy. Annals of Oncology. 32. S939–S940. 15 indexed citations

Duysinx, Bernard, et al.. (2021). [Small cell lung cancer : update of therapy].. RMLG. Revue médicale de Liège. 76(5-6). 452–457. 2 indexed citations

Duysinx, Bernard, et al.. (2021). [Managing of dyspnea in oncology].. RMLG. Revue médicale de Liège. 76(5-6). 432–439. 1 indexed citations

Sibille, Anne, et al.. (2021). [Pre-cancerous lung lesions and lung cancer screening].. RMLG. Revue médicale de Liège. 76(5-6). 440–445. 2 indexed citations

Sibille, Anne, et al.. (2021). Pembrolizumab‐Induced Migrating Cortico‐Subcortical Brain Lesions. Annals of Neurology. 89(6). 1255–1256.

10.

Onesti, Concetta Elisa, Hélène Schroeder, Andrée Rorive, et al.. (2020). 1720P How do oncological patients perceive the COVID-19 pandemic? Experience from CHU Liège in Belgium. Annals of Oncology. 31. S1010–S1010. 1 indexed citations

11.

Girard, Nicolas, Rainer Fietkau, Marina Chiara Garassino, et al.. (2020). 1242P Characteristics of the first 615 patients enrolled in Pacific R: A study of the first real-world data on unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy. Annals of Oncology. 31. S805–S806. 2 indexed citations

12.

Sibille, Anne, et al.. (2019). Granulomatosis With Polyangiitis in a Patient on Programmed Death-1 Inhibitor for Advanced Non-small-cell Lung Cancer. Frontiers in Oncology. 9. 478–478. 13 indexed citations

13.

Joris, Sofie, Thierry Pieters, Anne Sibille, et al.. (2019). Real life safety and effectiveness of nivolumab in older patients with non-small cell lung cancer: Results from the Belgian compassionate use program. Journal of Geriatric Oncology. 11(5). 796–801. 9 indexed citations

14.

Gester, Fanny, et al.. (2016). FACTEURS PRONOSTIQUES DU CANCER PULMONAIRE NON À PETITES CELLULES.. RMLG. Revue médicale de Liège. 71(1). 1 indexed citations

15.

Sibille, Anne, et al.. (2015). PRISE EN CHARGE DES TUMEURS EPITHELIALES THYMIQUES. RMLG. Revue médicale de Liège. 70(12). 1 indexed citations

16.

Sibille, Anne, Maryam Bourhaba, Nicole Barthélémy, et al.. (2015). [MANAGEMENT OF NON-SMALL CELL LUNG CANCER].. PubMed. 70(9). 432–41. 17 indexed citations

17.

Sibille, Anne, et al.. (2015). [MANAGEMENT OF THYMIC EPITHELIAL TUMORS].. PubMed. 70(12). 623–8. 1 indexed citations

18.

Sibille, Anne, et al.. (2012). MAINTENANCE THERAPY FOR ADVANCED NON-SMALL CELL LUNG CANCER: HOW DOES MY PATIENT FEEL ABOUT IT?. Journal of Thoracic Oncology. 7(6). 1 indexed citations

19.

Sibille, Anne, et al.. (2012). Maintenance Therapy for Advanced Non–Small-Cell Lung Cancer: A Pilot Study on Patients’ Perceptions. Journal of Thoracic Oncology. 7(8). 1291–1295. 18 indexed citations

20.

Sibille, Anne, et al.. (2012). Maintenance therapy for advanced non-small-cell lung cancer: ready for clinical practice?. Expert Review of Anticancer Therapy. 12(4). 529–539. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact